1. Background {#sec1}
=============

Abdominal aortic aneurysm (AAA) is a prevalent threat, affecting approximately 5% of males over the age of 65. Open aneurysm repair (OAR) has been performed since the 1950s with a 30-day mortality of 4--12% \[[@B1]\]. Since the early 1990s, endovascular repair (EVAR) of both elective and ruptured AAA has steadily increased. This was driven predominantly by early data reporting lower 30-day mortality rates of 1-2% \[[@B2]\]. Subsequent long-term follow-up data from both the EVAR 1 trial group as well as the DREAM trial suggested the mortality curves become equivalent as early as 1 year \[[@B3], [@B4]\]. Previous meta-analysis looked to address the 30-day mortality rates based on age and surgical experience as well as defining operative complications.

We performed a systemic review of the literature to analyze the rates of 30-day mortality, 30-day myocardial infarction, and hospital length of stay based on comparative observation and randomized control trials involving endovascular and open approach to elective and ruptured AAA repair.

2. Methods {#sec2}
==========

2.1. Data Sources and Study Selection {#sec2.1}
-------------------------------------

Two reviewers independently conducted the literature search and extraction of relevant articles from MEDLINE database, Embasse database, and Cochrane library for English language studies in humans older than 18 years of age. The date of the last search was obtained on July 1, 2012. We used the text words and related Medical Subject Headings terms: EVAR, outcome, mortality, morbidity, and endovascular aortic repair. We also searched relevant references cited in reviewed articles. We followed the guidelines of the Meta-Analysis of Observational Studies in Epidemiology Group in both the execution and the reporting of our findings \[[@B5]\]. Initial phase included review of the title and abstract of potentially relevant articles for inclusion in the review before retrieval of the full articles. We included observational studies and randomized control trials in adults which compared EVAR to OAR for repair of either ruptured or elective AAA ([Figure 1](#fig1){ref-type="fig"}). We included articles which reported rates of 30-day mortality, perioperative myocardial infarction rates, and hospital length of stay. We excluded duplicate publications or serial publications reporting on the same study population. Disagreements were resolved by consensus.

2.2. Data Extraction and Quality Assessment {#sec2.2}
-------------------------------------------

The following characteristics of the study were extracted: author, year, design, sample size, elective or ruptured AAA, AAA diameter, ICU length of stay, hospital length of stay, operative time, estimated operative blood loss, perioperative transfusion requirement, and age. Outcomes abstracted included incidence of perioperative myocardial infarction (MI), acute kidney injury (AKI), colon ischemia, leg ischemia, operative conversion rates to open repair, rates of endograft leak (specifically type 1 and type 2 endoleaks), and 30-day mortality.

All statistics were performed using Stata (Version 11, College Station, Texas). Two reviewers independently abstracted data and disagreements were resolved by consensus. Two reviewers independently rated study quality using the Newcastle-Ottawa scale for the assessment of the quality of observational studies \[[@B6]\].

2.3. Data Synthesis {#sec2.3}
-------------------

Our principal abstracted measure of effect was the odds ratio of a given outcome comparing EVAR to OAR. Univariate unadjusted outcomes were used and combined odds ratios were calculated to pool the odds ratio of individual study outcomes within the respective groups. Studies with no outcome event in either group were included for estimation of absolute incidence but could not be considered for calculation of the pooled odds ratio. Outcomes were pooled using a random effects (DerSimonian and Laird) model.

Heterogeneity was assessed by using the *I* ^2^ statistic. The *I* ^2^ statistic provides an estimate of the amount of variance due to heterogeneity rather than chance and is based on the traditional measure of variance, the Cochrane *Q* statistic. We conducted stratified analyses in order to assess potential confounders\' contribution to heterogeneity, including age, gender, and study quality (≤ or \> the median overall Newcastle-Ottawa score as well as individual component analysis). Publication bias was assessed using Begg and Egger\'s method. All *P* values were two-sided with an alpha of 0.05.

3. Results {#sec3}
==========

Baseline demographic data from the articles analyzed are included in [Table 1](#tab1){ref-type="table"} to include median patient age, AAA mean diameter, and study population size when reported. Forty-one trials ([Figure 2](#fig2){ref-type="fig"}) compared EVAR to OAR in elective AAA patients (7--46). A total of 1,594 deaths were reported in the EVAR population (506 deaths in the elective group) and mortality at 30 days favored EVAR with a pooled odds ratio of 0.34 (95% CI 0.31--0.38; *I* ^2^ = 73.5%; *P* \< 0.001). Eleven trials ([Figure 2](#fig2){ref-type="fig"}) compared EVAR to OAR in ruptured AAA patients \[[@B47]--[@B58]\]. EVAR was superior to OAR in the ruptured AAA population as well with a pooled odds ratio of 0.11 (95% CI 0.10--0.12; *I* ^2^ = 74.1%; *P* \< 0.001). Overall analysis of elective and ruptured AAA repair favored EVAR with respect to 30-day mortality with a pooled odds ratio of 0.19 (95% CI 0.17--0.20; *I* ^2^ = 88.9%; *P* \< 0.001). Looking specifically at 30-day mortality rates in the 4 randomized controlled trials included in the elective analysis, EVAR was favored with a pooled odds ratio of 0.50 (95% CI 0.28--0.88; *P* = 0.017; *I* ^2^ = 4.43; *P* = 0.219) ([Figure 3](#fig3){ref-type="fig"}) \[[@B2], [@B60]--[@B61]\].

Twenty-nine trials of elective AAA repair and 9 ruptured AAA repair trials were included in the analysis of MI ([Figure 4](#fig4){ref-type="fig"}) \[[@B30], [@B7]--[@B46]\]. There were a total of 1,835 events (1,806 events in the elective AAA repair population) reported in the EVAR group compared with 2,483 events (2,388 events in the elective AAA repair population) in the OAR group. The pooled odds ratio for elective AAA was 0.74 (95% CI 0.58--0.96; *P* = 0.02) in favor of EVAR. Ruptured AAA was 0.61 (95% CI 0.36--1.02; *P* = 0.06) suggesting a trend in favor of EVAR though did not rise to the level of statistical significance \[[@B48]--[@B50], [@B54]--[@B58], [@B63]\]. Pooled analysis of both elective and ruptured studies give an overall odds ratio of 0.74 (95% CI 0.62--0.89; *X* ^2^ = 39.87; *P* = 0.344).

Sixteen trials were analyzed for the effect of surgical approach on hospital length of stay \[[@B6], [@B60], [@B30], [@B7], [@B17], [@B19], [@B22], [@B27], [@B29], [@B14]--[@B32]\]. An average decrease in hospital length of stay of 129.12 hrs (95% CI 104.29--153.96 hrs, *P* \< 0.001) was observed in the EVAR group undergoing elective AAA repair ([Figure 5](#fig5){ref-type="fig"}). Two trials addressing ruptured AAA repair and hospital length of stay were analyzed \[[@B58], [@B62]\]. The average decrease in length of stay was 296.75 hrs (95% CI 156.68--436.82 hrs; *P* \< 0.001) in the EVAR population when compared to open repair. Combined analysis of elective and open AAA repair with regard to hospital length of stay demonstrated a decrease in 136.21 hrs (95% CI 111.73--160.68 hrs; *I* ^2^ = 97%; *P* \< 0.001) in favor of an endovascular approach.

4. Discussion {#sec4}
=============

In this study of pooled population of 37,781 patients with known AAA who underwent either EVAR or OAR in both the elective as well as the ruptured setting, EVAR appears to be favored with lower rates of not only 30-day mortality and average hospital length of stay but also myocardial infarction that is potentially associated with significant cost reduction without compromising outcomes.

In a similar meta-analysis performed by Lovegrove et al. of 21,178 patients who underwent either EVAR or OAR for elective AAA repair, EVAR was associated with shorter intensive care unit, total hospital stay, less cardiac and respiratory complications, and lower mortality rates \[[@B64]\]. However, myocardial infarction was not evaluated and was included in the large cardiac complication definition. In the ruptured setting, EVAR was associated with lower mortality rates than OAR with no difference in cardiac complications \[[@B63]\]. In our pooled data of 37,781 patients, EVAR was favored over OAR with statistically significantly lower rates of mortality and myocardial infarction with associated shorter hospital length of stay in both elective and ruptured setting. This result was observed in both observational as well as randomized clinical trials (RCT) but with less heterogeneity noted with RCT that we postulate is most likely related to variable experience of operators in different sites in EVAR versus OAR. This is in contrast to large volume RCT where operators underwent significant training period prior to site initiation, potentially leading to less complication and less heterogeneity in outcomes.

Pooled analysis of both elective and ruptured studies seems to favor EVAR with regards to perioperative risk for MI with a trend towards statistical significance. This data should be interpreted in the context of inherit selection bias regarding the patient population referred for EVAR (typically infrarenal anatomy, accommodating neck size, lack of complex anatomy, typically asymptomatic, smaller diameter, and without significant anatomic variation) compared with open repair. Additionally, patients referred for EVAR often have more significant comorbidity or acute illness precluding an open repair. Thus, this is critical in a population where the incidence of cardiovascular events is high at baseline to include postoperative MI in both the elective and the ruptured setting to identify an intervention that is associated over all with lower rates of postoperative MI.

There are limitations to this study design to include the observational design, heterogeneity of trials analyzed, variability in reporting various patient outcomes, and lack of individual patient data for covariates.

This study is one of the largest pooled data analysis of patients with known AAA who underwent either EVAR or OAR in the elective as well as the emergent (ruptured) setting. We demonstrated a statistically significant reduction in odds of 30-day mortality, myocardial infarction, and average hospital length of stay in AAA patients undergoing EVAR regardless of whether the procedure was elective or emergent in a large pooled patient\'s sample.

5. Conclusions {#sec5}
==============

EVAR has lower rates of 30-day mortality, 30-day myocardial infarction, and associated hospital length of stay based on our analysis of the pooled data from both observation and randomized control trials involving endovascular and open approach to elective and ruptured AAA repair.
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###### 

Baseline article demographics separated based on trial design and elective versus ruptured repair.

  Randomized control trials                          Publication year   EVAR/OAR, *n*   Age (EVAR/OAR)          AAA size, cm (EVAR/OAR)
  -------------------------------------------------- ------------------ --------------- ----------------------- -------------------------
  Matsumura et al. \[[@B60]\]                        2003               235/99          73 ± 0.5/70.1 ± 0.8     5.6 ± 0.1/5.9 ± 0.1
  Becquemin et al. \[[@B30]\]                        2011               150/149         68.9 ± 7.7/70 ± 7.1     5.5 ± 0.5/5.6 ± 0.7
  Prinssen et al. \[[@B61]\]                         2004               171/174         70.7 ± 6.6/69.5 ± 6.8   6.1 ± 0.9/6.0 ± 0.9
  Greenhalgh et al. \[[@B2]\]                        2004               626/626         74.1 ± 6.1/74 ± 6.1     6.4 ± 0.9/6.5 ± 1.0
                                                                                                                
  Observational trials                                                                                          
  Elective repairs                                                                                              
  Hansman et al. \[[@B7]\]                           2003               50/50           72.5 ± 8.4/72.1 ± 6.3   5.5 ± 0.9/6.2 ± 1.3
  Hynes and Sultan \[[@B8]\]                         2007               62/52           72.6 ± 6.3/74.6 ± 7.3   5.4 ± 1.1/6.2 ± 1.6
  Mistry et al. \[[@B9]\]                            2007               122/156         66/66                   5.7 ± 1.0/5.7 ± 1.0
  Moore et al. \[[@B10]\]                            1999               100/100         74.7 ± 7.9/72.9 ± 7.9   5.6 ± 1.1/5.9 ± 1.2
  May et al. \[[@B11]\]                              1998               108/195         70/69                   5.3/5.6
  May et al. \[[@B12]\]                              2001               148/135         72/69                   NR
  Moore et al. \[[@B13]\]                            2003               573/111         72.8 ± 7.8/71.6 ± 7.0   NR
  Paolini et al. \[[@B14]\]                          2008               81/69           83.7 ± 3.2/83.2 ± 2.8   5.8 ± 1.0/6.2 ± 1.3
  Porcellini et al. \[[@B15]\]                       2007               11/14           71.3/69.6               5.9/6.8
  Raval and Eskandari \[[@B16]\]                     2012               1634/391        \>80/\>80               NR
  Schermerhorn et al. \[[@B17]\]                     2008               22830/22830     76/76                   NR
  Schouten et al. \[[@B18]\]                         2005               55/69           74 ± 7.0/74 ± 6.0       6.0/6.0
  Steinmetz et al. \[[@B19]\]                        2010               148/134         78/76                   5.7 ± 0.9/5.7 ± 1.1
  Tefera et al. \[[@B20]\]                           2004               61/23           74/74                   6.0/6.0
  Teufelsbauer et al. \[[@B21]\]                     2002               206/248         73.4/70.6               NR
  Turnipseed et al. \[[@B22]\]                       2003               70/96           73/70                   5.9/5.8
  Wahlgren and Malmstedt \[[@B23]\]                  2008               217/483         74 ± 7/71 ± 8           NR
  Wang and Carpenter \[[@B24]\]                      2008               2664/334        73.1 ± 7.8/70 ± 7.8     5.6 ± 1.0/5.7 ± 1.2
  Zeebregts et al. \[[@B25]\]                        2004               93/82           70.9 ± 8.8/69.1 ± 7.7   6.0 ± 1.1/6.4 ± 1.3
  Aarts et al. \[[@B26]\]                            2005               99/116          NR                      5.8/6.0
  Arko et al. \[[@B27]\]                             2002               174/243         73.5 ± 8.1/73.4 ± 7.8   5.8 ± 0.9/6.4 ± 0.2
  de Bruin et al. \[[@B28]\]                         2010               173/178         70.7 ± 6.6/69.6 ± 6.8   NR
  Becquemin et al. \[[@B29]\]                        2000               73/107          70/69                   5.0 ± 0.5/5.1 ± 1.1
  Brown et al. \[[@B31]\]                            2011               543/539         74.2 ± 6/74 ± 6.1       6.5 ± 0.9/6.5 ± 0.9
  Bush et al. \[[@B32]\]                             2007               788/1580        72.9 ± 6.7/71.8 ± 6.4   NR
  Cao et al. \[[@B33]\]                              2004               534/585         73/72                   5.2/5.6
  de Virgilio et al. \[[@B34]\]                      1999               83/63           73/68                   NR
  Chan et al. \[[@B35]\]                             2007               157/329         75/72                   6.1/6.3
  Chisci et al. \[[@B36]\]                           2009               74/61           77.5 ± 7/67.8 ± 8.7     6.2/6.3
  Criado et al. \[[@B37]\]                           2003               240/126         75.5/70                 5.70.96/NR
  Elkouri et al. \[[@B38]\]                          2004               94/261          77/73                   5.7/5.7
  García-Madrid et al. \[[@B39]\]                    2004               53/30           73/70                   6.2/6.4
  Gawenda et al. \[[@B40]\]                          2003               10/16           57/52.5                 NR
  Gou$\overset{¨}{\text{e}}$ffic et al. \[[@B41]\]   2005               209/289         71 ± 8/69 ± 8           5.2 ± 0.9/5.4 ± 1.5
  Gupta et al. \[[@B42]\]                            2012               369/282         56/56                   NR
  Hill et al. \[[@B44]\]                             2002               79/70           74 ± 8/72 ± 8           5.9 ± 0.9/5.9 ± 1.4
  Diehm et al. \[[@B45]\]                            2008               25/25           62 ± 2.8/59 ± 3.9       5.0 ± 0.7/5.5 ± 1.0
  Hoshina et al. \[[@B46]\]                          2012               326/247         75.8 ± 6.3/74.7 ± 8     5.2 ± 1.0/5.4 ± 1.1
                                                                                                                
  Ruptured Repairs                                                                                              
  Mcphee et al. \[[@B47]\]                           2009               3179/24571      74.3/73                 N/A
  Nedeau et al. \[[@B48]\]                           2012               19/55           78.2/76.3               N/A
  Saqib et al. \[[@B49]\]                            2012               37/111          74.9 ± 8.2/75.6 ± 8.4   N/A
  Sarac et al. \[[@B50]\]                            2011               32/128          80.5/72                 N/A
  Sharif et al. \[[@B51]\]                           2007               52/74           74/74                   N/A
  Vaddineni et al. \[[@B52]\]                        2005               9/15            70.8 ± 2.9/72.2 ± 5.5   N/A
  Verhoeven et al. \[[@B53]\]                        2008               36/89           72 ± 8.7/72 ± 8.7       N/A
  Visser et al. \[[@B54]\]                           2009               58/143          73.2 ± 8.6/73.5 ± 7.5   N/A
  Alsac et al. \[[@B55]\]                            2005               17/20           72.9 ± 9.8/72.8 ± 7.8   N/A
  Coppi et al. \[[@B56]\]                            2006               25/33           72.2 ± 8.2/74.3 ± 7.1   N/A
  Bosch et al. \[[@B57]\]                            2010               33/91           81/77                   N/A
  Franks et al. \[[@B58]\]                           2006               21/22           73.7 ± 6.3/71.8 ± 5.7   N/A
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